Stay updated with breaking news from Primrose Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) will host its Investor and Analyst Day on Tuesday, December 12, 2023.Members of Ligand’s senior management team will provide an update on the company’s strategy and portfolio as well as a multi-year financial outlook and a 2024 guidance p...
Ligand Pharmaceuticals Incorporated will host its Investor and Analyst Day on Tuesday, December 12, 2023. Members of Ligand’s senior management team will provide an update on the company’s...
Ligand Pharmaceuticals Incorporated will host its Investor and Analyst Day on Tuesday, December 12, 2023. Members of Ligand's senior management team will provide an update on the company's strategy and portfolio as well as a multi-year financial...
Operator: Thank you for standing by. My name is Danika and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Ligand Third Quarter 2023 Earnings Webcast.
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q3 2023 Earnings Call Transcript November 8, 2023 Ligand Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $1.02, expectations were $0.68. Operator: Thank you for standing by. My name is Danika and I’ll be your conference operator today. At this time, I’d like to welcome everyone to the Ligand Third Quarter […]